BUSINESS● LOWSep 8 · Sep 8, 2026, 9:38 AM

Switzerland's Sandoz aims to double sales by 2035 in expanded biosimilars push

Seeking Alpha Tech · western europe

Switzerland's Sandoz aims to double its sales by 2035, driven by an expanded push into biosimilars. This indicates the company's long-term growth strategy within the pharmaceutical market.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSEC BUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSEC BUSINESSnowWhy Ecobank's opening to the yuan changes the game for the continentJeune Afrique BUSINESS20m agoIndia, U.S. ironing out differences on trade deal; nearing 'landing point': JaishankarThe Hindu